Drugs Medical Pharma

Opinion: Which parent are you? ‘Helicopter,’ toxic or stressed?

By Dr Aparna S February 27, 2024: Parents who have adolescents may be tough as old boots, excessively involved in bringing up their.

Read More
Drugs Health Pharma

Omalizumab or Xolair can lower risk of food allergies in kids, adults: NIH

HQ Team February 26, 2024: An asthma drug, omalizumab, can “significantly” reduce the risk of allergic reactions caused by multiple foods among children.

Read More
Drugs Health Pharma

Chronic stress may accelerate cancer growth, American scientists say

HQ Team February 26, 2024: Chronic stress may be a factor in spreading cancer, according to scientists from Cold Spring Harbor Laboratory. “Chronic.

Read More
Drugs Health Pharma

European regulator backs Biogen’s drug for amyotrophic lateral sclerosis

HQ Team February 24, 2024: Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug.

Read More
Drugs Health Pharma

Toxinologists: Single universal snake antivenom jab is within range

HQ Team February 23, 2024: A single universal shot of antivenom for snake bites is not far away after scientists found a potent.

Read More
Drugs Health Pharma

Scientists discover drug to treat deadly malignant pleural mesothelioma

HQ Team February 2024: Scientists have developed a drug to treat malignant pleural mesothelioma, a fatal form of cancer that affects the lining.

Read More
Climate Health Pharma

Toxic mercury levels remain stagnant in tuna for last 53 years: Study

HQ Team February 22, 2024: Eating tuna may expose humans to methylmercury, a toxic chemical that affects the central nervous system, and the.

Read More
Drugs Health Pharma

Exercises help women more than men, cut risk of premature death

HQ Team February 21, 2024: Women stand to benefit more than men when they indulge in physical activities as it lowers the risk.

Read More
Drugs Health Pharma

Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use

HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.

Read More
Drugs Health Pharma

Harvard researchers create superbug killer molecule cresomycin

 HQ Team February 20, 2024: A new weapon to kill superbugs may be on the horizon after researchers at the Cambridge, Massachusetts-based Harvard.

Read More